✦ LIBER ✦

JAK2 V617F negative essential thrombocythemia

✍ Scribed by Kashif, A.W.; Aggarwal, Sameer; Verma, Tarun; Gupta, R.M.

Book ID: 123332678
Publisher: Armed Forces Medical Services, India
Year: 2013
Tongue: English
Weight: 903 KB
Volume: 69
Category: Article
ISSN: 0377-1237
DOI: 10.1016/j.mjafi.2012.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene expression profiling distinguishes

Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia

✍ Puigdecanet, E; Espinet, B; Lozano, J J; Sumoy, L; Bellosillo, B; Arenillas, L; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 331 KB

Clinical significance of clonality asses

Clinical significance of clonality assessment in JAK2V617F-negative essential thrombocythemia

✍ Luz Martínez-Avilés, Alberto Álvarez-Larrán, Carles Besses… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 241 KB

Absence of FTL3 mutations in patients wi

Absence of FTL3 mutations in patients with JAK2V617F mutation negative essential thrombocythemia

✍ Bruno C. Medeiros; Tong Zhang; Jeffrey H. Lipton; Suzanne Kamel-Reid 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB 👁 1 views

Thrombocytosis in rheumatoid arthritis:

Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia

✍ Ozlem Cırpan Ayvaz; Irfan Yavasoglu; Gurhan Kadikoylu; Gokay Bozkurt; Zahit Bola 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 214 KB

Clinical implications of the JAK2 V617F

Clinical implications of the JAK2 V617F mutation in essential thrombocythemia

✍ Antonioli, E; Guglielmelli, P; Pancrazzi, A; Bogani, C; Verrucci, M; Ponziani, V 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 91 KB

Clinical correlates of JAK2V617F allele

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia

✍ Jaya Kittur; Ryan A. Knudson; Terra L. Lasho; Christy M. Finke; Naseema Gangat; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

## Abstract ## BACKGROUND. __JAK2__V617F occurs in approximately 50% of patients with essential thrombocythemia (ET). Qualitative studies of mutation analysis have previously reported an association between __JAK2__V617F and advanced age, higher hemoglobin level, higher leukocyte count, and lower